Citigroup analyst Steven Enders initiates coverage on Intuit (NASDAQ:INTU) with a Buy rating and announces Price Target of $538.
Where Inari Medical Stands With Analysts
Analysts have provided the following ratings for Inari Medical (NASDAQ:NARI) within the last quarter: